Microbot Medical, Inc (MBOT) Price to Earnings Ratio

Microbot Medical Inc. (MBOT) develops surgical microrobots, relying on external precision component suppliers under strict quality control. Market fluctuations in the share price on GURU.Markets are currently recorded at -4.50. Business development is based on the implementation of the LIBERTY system, FDA approval, and the transition to minimally invasive treatment methods through partnerships with major clinics.

Microbot Medical (MBOT) - P/E Multiple from 07/04/2022 to 11/10/2026

Analytical breakdowns for Microbot Medical Inc.

- price and consensus price forecast:

Stock Price microbotmedical.com|MBOT - Price Target Chart

- market capitalization details:

Market Value Microbot Medical Inc.|MBOT - Real Price to Acquire Entire Company

- book capitalization information:

Accounting Value of a Share Microbot Medical|MBOT - Book Capitalization|Market Capitalization to Book Value microbotmedical.com|MBOT - Aggregate Company Assets

- debt obligations and liquidity statistics:

- earnings and valuation multiples indicators:

MBOT - Company Net Income|Future Profit Microbot Medical Inc.|MBOT - P/E Multiple|Projected Price to Earnings Ratio Microbot Medical, Inc.|MBOT - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Microbot Medical Inc.|MBOT - Operating profit before deduction of amortization|Earnings per share for the last four quarters Microbot Medical|MBOT - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months microbotmedical.com|MBOT - Earnings per share growth in current year|Expected earnings per share growth for next year Microbot Medical Inc.

General company analysis:microbotmedical.com, MBOT

Investors seek assets with sustainable business models while avoiding value traps. The P/E ratio measures a stock's market value relative to net income, determining the payback period for investments. For Microbot Medical Inc. (MBOT), this calculation reflects the investment efficiency in a staff of elite roboticists developing microsurgical systems. Analyzing the current P/E of the business helps distinguish temporary price dips from a systemic crisis of fundamental indicators.

Analysis of competing companies